loadpatents
name:-0.047080993652344
name:-0.038881063461304
name:-0.0024538040161133
SUMMA; Vincenzo Patent Filings

SUMMA; Vincenzo

Patent Applications and Registrations

Patent applications and USPTO patent grants for SUMMA; Vincenzo.The latest application filed is for "oxalamido-substituted tricyclic inhibitors of hepatitis b virus".

Company Profile
1.29.39
  • SUMMA; Vincenzo - Pomezia RM
  • Summa; Vincenzo - Pomezia IT
  • Summa; Vincenzo - Rome IT
  • Summa; Vincenzo - Roma IT
  • Summa; Vincenzo - Velletri IT
  • Summa; Vincenzo - Pomezia Rome
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Oxalamido-substituted Tricyclic Inhibitors Of Hepatitis B Virus
App 20220241241 - DE FRANCESCO; Raffaele ;   et al.
2022-08-04
Tricyclic Inhibitors Of Hepatitis B Virus
App 20220110943 - DE FRANCESCO; Raffaele ;   et al.
2022-04-14
Inhibitors Of Hepatitis B Virus
App 20210276967 - DE FRANCESCO; Raffaele ;   et al.
2021-09-09
Compounds for use in the treatment of kinetoplastid infection
Grant 10,815,222 - Biancofiore , et al. October 27, 2
2020-10-27
Compounds For Use In The Treatment Of Kinetoplastid Infection
App 20200095232 - BIANCOFIORE; Ilaria ;   et al.
2020-03-26
HCV NS3 protease inhibitors
Grant 9,738,661 - Liverton , et al. August 22, 2
2017-08-22
Compounds for use in the treatment of disorders that are ameliorated by inhibition of HDAC
Grant 9,371,295 - Altamura , et al. June 21, 2
2016-06-21
Compounds for use in the treatment of parasitic diseases
Grant 9,365,541 - Altamura , et al. June 14, 2
2016-06-14
HCV NS3 protease inhibitors
Grant 9,328,138 - Rudd , et al. May 3, 2
2016-05-03
Compounds For Use In The Treatment Of Parasitic Diseases
App 20150299163 - ALTAMURA; Sergio ;   et al.
2015-10-22
HCV NS3 Protease Inhibitors
App 20150266897 - Liverton; Nigel J. ;   et al.
2015-09-24
Compounds For Use In The Treatment Of Disorders That Are Ameliorated By Inhibition Of Hdac
App 20150218112 - Altamura; Sergio ;   et al.
2015-08-06
Macrocyclic compounds as antiviral agents
Grant 8,927,569 - Harper , et al. January 6, 2
2015-01-06
Compositions Useful For The Treatment Of Viral Diseases
App 20140328799 - Carroll; Steven S. ;   et al.
2014-11-06
Hcv Ns3 Protease Inhibitors
App 20140296136 - Rudd; Michael T. ;   et al.
2014-10-02
Hcv Ns3 Protease Inhibitors
App 20130178413 - McCauley; John A. ;   et al.
2013-07-11
HCV NS3 protease inhibitors
Grant 8,377,873 - Liverton , et al. February 19, 2
2013-02-19
Process for preparing N-alkylated hydroxypyrimidinone compounds
Grant 8,357,798 - Belyk , et al. January 22, 2
2013-01-22
Macrocyclic compounds as antiviral agents
Grant 8,314,062 - Crescenzi , et al. November 20, 2
2012-11-20
Nucleoside derivatives as inhibitors of viral polymerases
Grant 8,183,216 - Di Francesco , et al. May 22, 2
2012-05-22
Macrocyclic compounds as antiviral agents
Grant 8,178,520 - Di Francesco , et al. May 15, 2
2012-05-15
HCV NS3 protease inhibitors
Grant 8,138,164 - Liverton , et al. March 20, 2
2012-03-20
Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
Grant 8,080,654 - Harper , et al. December 20, 2
2011-12-20
Nucleoside Derivatives As Inhibitors Of Viral Polymerases
App 20110306573 - Avolio; Salvatore ;   et al.
2011-12-15
Hiv Integrase Inhibitors
App 20110257162 - Summa; Vincenzo ;   et al.
2011-10-20
Macrocyclic Quinoxaline Compounds As Hcv Ns3 Protease Inhibitors
App 20110224134 - Harper; Steven ;   et al.
2011-09-15
HIV integrase inhibitors
Grant 7,981,879 - Summa , et al. July 19, 2
2011-07-19
Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
Grant 7,973,040 - Harper , et al. July 5, 2
2011-07-05
Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors
Grant 7,968,553 - Crescenzi , et al. June 28, 2
2011-06-28
HIV integrase inhibitors
Grant 7,939,537 - Summa , et al. May 10, 2
2011-05-10
N-substituted Hydroxypyrimidinone Carboxamide Inhibitors Of Hiv Integrase
App 20110034449 - Crescenzi; Benedetta ;   et al.
2011-02-10
HCV NS3 Protease Inhibitors
App 20100317623 - Liverton; Nigel J. ;   et al.
2010-12-16
HCV NS3 Protease Inhibitors
App 20100298210 - Liverton; Nigel J. ;   et al.
2010-11-25
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,820,660 - Crescenzi , et al. October 26, 2
2010-10-26
Nucleoside Derivatives as Inhibitors of Viral Polymerases
App 20100210581 - Di Francesco; Maria Emilia ;   et al.
2010-08-19
Macrocyclic Compounds As Antiviral Agents
App 20100183551 - Harper; Steven ;   et al.
2010-07-22
HCV NS3 Protease Inhibitors
App 20100099695 - Liverton; Nigel J. ;   et al.
2010-04-22
Macrocyclic Quinoxaline Compounds as HCV NS3 Protease Inhibitors
App 20100029666 - Harper; Steven ;   et al.
2010-02-04
Macrocyclic Compounds as Antiviral Agents
App 20090312241 - Crescenzi; Benedetta ;   et al.
2009-12-17
Macrocyclic Compounds As Antiviral Agents
App 20090258891 - Di Francesco; Maria Emilia ;   et al.
2009-10-15
HIV Integrase Inhibitors
App 20090253681 - Summa; Vincenzo ;   et al.
2009-10-08
Hiv Integrase Inhibitors
App 20090221571 - Summa; Vincenzo ;   et al.
2009-09-03
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
Grant 7,459,452 - Di Francesco , et al. December 2, 2
2008-12-02
N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20080275004 - Crescenzi; Benedetta ;   et al.
2008-11-06
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,435,734 - Crescenzi , et al. October 14, 2
2008-10-14
Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
Grant 7,414,045 - Crescenzi , et al. August 19, 2
2008-08-19
Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors
App 20080176869 - Crescenzi; Benedetta ;   et al.
2008-07-24
Hiv integrase inhibitors
App 20070161639 - Jones; Philip ;   et al.
2007-07-12
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
Grant 7,232,819 - Di Francesco , et al. June 19, 2
2007-06-19
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20070123524 - Crescenzi; Benedetta ;   et al.
2007-05-31
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,217,713 - Crescenzi , et al. May 15, 2
2007-05-15
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
App 20070083045 - Di Francesco; Maria E. ;   et al.
2007-04-12
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,169,780 - Crescenzi , et al. January 30, 2
2007-01-30
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20060258860 - Crescenzi; Benedetta ;   et al.
2006-11-16
Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors
Grant 7,091,209 - Gardelli , et al. August 15, 2
2006-08-15
Potassium salt of an HIV integrase inhibitor
App 20060122205 - Belyk; Kevin M. ;   et al.
2006-06-08
Enzyme inhibitors
Grant 7,022,736 - Neuner , et al. April 4, 2
2006-04-04
Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors
App 20060046985 - Crescenzi; Benedetta ;   et al.
2006-03-02
Pyrimidinone viral polymerase inhibitors
App 20050130997 - Avolio, Salvatore ;   et al.
2005-06-16
Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
App 20050075356 - Di Francesco, Maria E. ;   et al.
2005-04-07
N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
App 20050025774 - Crescenzi, Benedetta ;   et al.
2005-02-03
Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
App 20040106627 - Gardelli, Cristina ;   et al.
2004-06-03
Enzyme inhibitors
App 20030207922 - Neuner, Philippe Jean Sigfried ;   et al.
2003-11-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed